| dbo:abstract
|
- EXP-561 is an investigational drug that acts as an inhibitor of the reuptake of serotonin, dopamine, and norepinephrine. It was developed in the 1960s by Du Pont and was suggested as a potential antidepressant but failed in trials and was never marketed. (en)
- EXP-561，即4-苯基双环[2.2.2]辛-1-胺，是一种有机化合物，化学式为C14H19N。它可以被3-氯过氧苯甲酸氧化为1-硝基-4-苯基双环[2.2.2]辛烷。在碳酸钾的存在下，它可以和1-溴-2-甲氧基乙烷在乙腈中加热反应，得到N-(2-甲氧基乙基)-4-苯基双环[2.2.2]辛-1-胺。 1960年代，它被杜邦公司发展 并被提名为一种抗抑郁药，不过失败了，也没有上市过。 (zh)
|
| dbo:casNumber
| |
| dbo:fdaUniiCode
| |
| dbo:pubchem
| |
| dbo:thumbnail
| |
| dbo:wikiPageID
| |
| dbo:wikiPageLength
|
- 4173 (xsd:nonNegativeInteger)
|
| dbo:wikiPageRevisionID
| |
| dbo:wikiPageWikiLink
| |
| dbp:atcPrefix
| |
| dbp:c
| |
| dbp:casNumber
|
- 10206 (xsd:integer)
- 10207 (xsd:integer)
- 16142 (xsd:integer)
|
| dbp:chemspiderid
| |
| dbp:h
| |
| dbp:index2Label
| |
| dbp:index3Label
|
- hydrochloride monohydrate (en)
|
| dbp:iupacName
| |
| dbp:legalStatus
| |
| dbp:n
| |
| dbp:pubchem
| |
| dbp:routesOfAdministration
| |
| dbp:smiles
| |
| dbp:unii
| |
| dbp:wikiPageUsesTemplate
| |
| dcterms:subject
| |
| gold:hypernym
| |
| rdf:type
| |
| rdfs:comment
|
- EXP-561 is an investigational drug that acts as an inhibitor of the reuptake of serotonin, dopamine, and norepinephrine. It was developed in the 1960s by Du Pont and was suggested as a potential antidepressant but failed in trials and was never marketed. (en)
- EXP-561，即4-苯基双环[2.2.2]辛-1-胺，是一种有机化合物，化学式为C14H19N。它可以被3-氯过氧苯甲酸氧化为1-硝基-4-苯基双环[2.2.2]辛烷。在碳酸钾的存在下，它可以和1-溴-2-甲氧基乙烷在乙腈中加热反应，得到N-(2-甲氧基乙基)-4-苯基双环[2.2.2]辛-1-胺。 1960年代，它被杜邦公司发展 并被提名为一种抗抑郁药，不过失败了，也没有上市过。 (zh)
|
| rdfs:label
|
- EXP-561 (en)
- EXP-561 (zh)
|
| owl:sameAs
| |
| prov:wasDerivedFrom
| |
| foaf:depiction
| |
| foaf:isPrimaryTopicOf
| |
| is dbo:wikiPageWikiLink
of | |
| is foaf:primaryTopic
of | |
